Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysis

30 Jul 2021

Abstract excerpt

OBJECTIVE: Incidence of both Type 2 diabetes mellitus (T2DM) and hepatocellular carcinoma (HCC) are rapidly increasing worldwide. One of the leading causes of HCC is hepatitis C virus (HCV), which is a resource of blood-borne viral infection. HCV increases the risk for HCC probably by promoting fibrosis and cirrhosis. Association among T2DM and HCV related HCC remains significant, indicating that such association...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Bioinformatics and Genomic Networks
Share to Ferroptosis and cancer prognosis
Share to GDF15 and Related Biomarkers

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 34588861
DOI: 10.1016/j.sjbs.2021.07.068

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 8 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Identifying key genes and screening therapeutic agents associated with diabetes mellitus and HCV-related hepatocellular carcinoma by bioinformatics analysisPMID 34588861Read ↗

Identification and analysis of key genes and signaling pathways associated with Type 1 diabetes mellitus by bioinformatics analysis of next generation sequencing dataSemantic proximity Read ↗

Analysis of key genes and pathways associated with the pathogenesis of Type 2 diabetes mellitusSemantic proximity Read ↗

Single-Cell RNA Sequencing Analysis of Key Candidate Genes; Molecular Modeling and Docking-Based Therapeutic Molecules Exploration of Nature Derived Phytoconstituents for Type 2 Diabetes Mellitus.Semantic proximity Read ↗

Screening and function analysis of hub genes and pathways in hepatocellular carcinoma via bioinformatics approachesSemantic proximity Read ↗

Identification of Hub Genes in Type 2 Diabetes Mellitus Using Bioinformatics AnalysisSemantic proximity Read ↗

Identification of hub genes and potential drugs in hepatocellular carcinoma through integrated bioinformatics analysisSemantic proximity Read ↗

CDK1, CCNB1, CDC20, BUB1, MAD2L1, MCM3, BUB1B, MCM2, and RFC4 May Be Potential Therapeutic Targets for Hepatocellular Carcinoma Using Integrated Bioinformatic AnalysisSemantic proximity Read ↗

Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysisSemantic proximity Read ↗

Gene expression profiling and protein-protein network analysis revealed prognostic hub biomarkers linking cancer risk in type 2 diabetic patientsSemantic proximity Read ↗

Investigation of the pathogenesis of liver cirrhosis associated with type 2 diabetes mellitus via bioinformatic analysisSemantic proximity Read ↗

Identification of candidate biomarkers and pathways associated with type 1 diabetes mellitus using bioinformatics analysisSemantic proximity Read ↗

Multi-omics regulatory networks reveal the key driver genes in the development of type 2 diabetesSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.